Conference Paper: Anti-tumor efficacy of a recombinant human arginase in combination with chemotherapeutic agents in human hepatocellular carcinoma

File Download Links for fulltext
(May Require Subscription)
Supplementary
  • Basic View
  • Metadata View
  • XML View
TitleAnti-tumor efficacy of a recombinant human arginase in combination with chemotherapeutic agents in human hepatocellular carcinoma
AuthorsChow, A
Pang, R
Chu, A
Ng, L
Poon, R
KeywordsMedical sciences
Oncology
Issue Date2011
PublisherAmerican Association for Cancer Research. The Journal's web site is located at http://cancerres.aacrjournals.org/
CitationThe 102nd Annual Meeting of the American Association for Cancer Research (AACR 2011), Orlando, FL., 2-6 April 2011. In Cancer Research, 2011, v. 71 n. 8, suppl. 1, abstract no. 5382 [How to Cite?]
DOI: http://dx.doi.org/10.1158/1538-7445.AM2011-5382
AbstractINTRODUCTION: Systemic chemotherapy of hepatocellular carcinoma (HCC) relies on few drugs and the response rates are low especially in patients with advanced HCC. HCC is considered as auxotrophic for arginine due to the lack of expression of argininosuccinate synthetase (ASS). Several recombinant human arginases were found to be effective in inhibiting liver, pancreatic and leukemic cell proliferation. Recently ...
DescriptionThis journal suppl. is conference proceedings of AACR 2011
Poster Presentations - Enhancing Efficacy of Targeted Agents: abstract no. 5382
ISSN0008-5472
2011 Impact Factor: 7.856
2011 SCImago Journal Rankings: 1.309
DOIhttp://dx.doi.org/10.1158/1538-7445.AM2011-5382
DC Field
Value
dc.contributor.authorChow, A
dc.contributor.authorPang, R
dc.contributor.authorChu, A
dc.contributor.authorNg, L
dc.contributor.authorPoon, R
dc.date.accessioned2011-08-26T14:36:59Z
dc.date.available2011-08-26T14:36:59Z
dc.date.issued2011
dc.description.abstractINTRODUCTION: Systemic chemotherapy of hepatocellular carcinoma (HCC) relies on few drugs and the response rates are low especially in patients with advanced HCC. HCC is considered as auxotrophic for arginine due to the lack of expression of argininosuccinate synthetase (ASS). Several recombinant human arginases were found to be effective in inhibiting liver, pancreatic and leukemic cell proliferation. Recently ...
dc.description.naturelink_to_OA_fulltext
dc.descriptionThis journal suppl. is conference proceedings of AACR 2011
dc.descriptionPoster Presentations - Enhancing Efficacy of Targeted Agents: abstract no. 5382
dc.description.otherThe 102nd Annual Meeting of the American Association for Cancer Research (AACR 2011), Orlando, FL., 2-6 April 2011. In Cancer Research, 2011, v. 71 n. 8, suppl. 1, abstract no. 5382
dc.identifier.citationThe 102nd Annual Meeting of the American Association for Cancer Research (AACR 2011), Orlando, FL., 2-6 April 2011. In Cancer Research, 2011, v. 71 n. 8, suppl. 1, abstract no. 5382 [How to Cite?]
DOI: http://dx.doi.org/10.1158/1538-7445.AM2011-5382
dc.identifier.doihttp://dx.doi.org/10.1158/1538-7445.AM2011-5382
dc.identifier.hkuros191920
dc.identifier.issn0008-5472
2011 Impact Factor: 7.856
2011 SCImago Journal Rankings: 1.309
dc.identifier.issue8, suppl. 1
dc.identifier.urihttp://hdl.handle.net/10722/137925
dc.identifier.volume71
dc.languageeng
dc.publisherAmerican Association for Cancer Research. The Journal's web site is located at http://cancerres.aacrjournals.org/
dc.publisher.placeUnited States
dc.relation.ispartofCancer Research
dc.subjectMedical sciences
dc.subjectOncology
dc.titleAnti-tumor efficacy of a recombinant human arginase in combination with chemotherapeutic agents in human hepatocellular carcinoma
dc.typeConference_Paper